Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
Lin Jiang(Fudan University Shanghai Cancer Center), Guan-Hua Su(Fudan University Shanghai Cancer Center), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Yajia Gu(Fudan University Shanghai Cancer Center), He Wang(Shanghai Center for Brain Science and Brain-Inspired Technology), Rencheng Zheng(Shanghai Center for Brain Science and Brain-Inspired Technology), Chao You(Fudan University Shanghai Cancer Center), Bingqing Xia(Chinese Academy of Sciences), Yi Xiao(Fudan University Shanghai Cancer Center), Dandan Zhang(Sun Yat-sen University)
Cited by 92
Related Papers
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
|Cell Research|2021|198
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143